By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


3SBio Inc. 

3 A1, Road 10
Economy & Technology Development Zone
Shenyang    110027  China
Phone: 86-24-2581-1820 Fax:


Company News
3SBio Inc. (SSRX) Selected As A Constituent Of The MSCI China Index 5/13/2016 7:54:07 AM
3SBio Inc. (SSRX) Approved For Trials Of PEG-Irinotecan 3/8/2016 9:35:02 AM
3SBio Inc. (SSRX)'s PEG-irinotecan Wins IND Approval From China FDA 3/7/2016 7:26:03 AM
3SBio Inc. (SSRX) Announces Expansion Of Its Leadership Team 3/4/2016 6:33:38 AM
Aurinia (ISA.TO)/3SBio Inc. (SSRX) Drug Effective Against Lupus Nephritis 2/25/2016 8:56:50 AM
3SBio Inc. (SSRX) Acquires Control Of CP Guojian In $213 Million Deal 12/1/2015 11:07:08 AM
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For ALT-P7, An Antibody-Drug Conjugate Targeting HER2 With Alteogen 10/12/2015 6:20:33 AM
3SBio Inc. (SSRX) Selected As A Constituent Of The Hang Seng Composite LargeCap & MidCap Index 8/17/2015 9:33:36 AM
Week In Review: 3SBio Inc. (SSRX) Acquires Wansheng Pharma For $85 Million 7/27/2015 7:50:28 AM
3SBio Inc. (SSRX) Acquires Zhejiang Wansheng Pharmaceutical 7/24/2015 7:54:14 AM